$24.7 Billion is the total value of VIKING GLOBAL INVESTORS LP's 91 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ROIVANT SCIENCES LTD | $435,899,000 | -51.0% | 88,238,700 | 0.0% | 1.76% | -31.2% | ||
| ADPT | ADAPTIVE BIOTECHNOLOGIES COR | $416,313,000 | -50.5% | 29,993,708 | 0.0% | 1.68% | -30.6% | |
| BBIO | BRIDGEBIO PHARMA INC | $270,203,000 | -39.1% | 26,620,991 | 0.0% | 1.09% | -14.6% | |
| RIVIAN AUTOMOTIVE INC | $160,989,000 | -51.5% | 3,204,389 | 0.0% | 0.65% | -32.0% | ||
| INBX | INHIBRX INC | $118,215,000 | -49.0% | 5,305,866 | 0.0% | 0.48% | -28.4% | |
| GUARDANT HEALTH INCnote 11/1 | $96,852,000 | -20.6% | 120,000,000 | 0.0% | 0.39% | +11.7% | ||
| FDMT | 4D MOLECULAR THERAPEUTICS IN | $59,541,000 | -31.1% | 3,937,914 | 0.0% | 0.24% | -3.2% | |
| TALS | TALARIS THERAPEUTICS INC | $32,370,000 | -35.6% | 3,289,617 | 0.0% | 0.13% | -9.7% | |
| RALLYBIO CORP | $29,280,000 | -26.8% | 4,194,777 | 0.0% | 0.12% | +2.6% | ||
| EWTX | EDGEWISE THERAPEUTICS INC | $26,454,000 | -36.5% | 2,727,249 | 0.0% | 0.11% | -10.8% | |
| OLAPLEX HLDGS INC | $25,214,000 | -46.3% | 1,613,189 | 0.0% | 0.10% | -24.4% | ||
| KNTE | KINNATE BIOPHARMA INC | $20,498,000 | -36.5% | 1,820,462 | 0.0% | 0.08% | -10.8% | |
| DAWN | DAY ONE BIOPHARMACEUTICALS I | $11,482,000 | -41.1% | 1,157,424 | 0.0% | 0.05% | -17.9% | |
| LIANBIOsponsored ads | $5,565,000 | -39.8% | 1,500,000 | 0.0% | 0.02% | -18.5% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VISA INC | 36 | Q3 2023 | 7.0% |
| AMAZON COM INC | 34 | Q3 2023 | 10.6% |
| META PLATFORMS INC | 34 | Q3 2023 | 10.4% |
| MICROSOFT CORP | 30 | Q3 2023 | 9.1% |
| THERMO FISHER SCIENTIFIC INC | 29 | Q3 2023 | 5.4% |
| NETFLIX INC | 26 | Q2 2023 | 6.0% |
| MASTERCARD INCORPORATED | 25 | Q3 2023 | 3.9% |
| ELEVANCE HEALTH INC | 24 | Q2 2023 | 10.2% |
| ALPHABET INC | 22 | Q2 2021 | 9.3% |
| UNITEDHEALTH GROUP INC | 22 | Q3 2023 | 5.3% |
View VIKING GLOBAL INVESTORS LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Celldex Therapeutics, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Coupa Software IncSold out | February 14, 2023 | 0 | 0.0% |
| FIGS, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Guardant Health, Inc. | February 14, 2023 | 4,107,644 | 4.0% |
| Orion Acquisition Corp.Sold out | February 14, 2023 | 0 | 0.0% |
| PROCEPT BioRobotics CorpSold out | February 14, 2023 | 0 | 0.0% |
| Frazier Lifesciences Acquisition CorpSold out | November 25, 2022 | 0 | 0.0% |
| Cazoo Group Ltd | November 10, 2022 | 60,000,000 | 7.3% |
| AbCellera Biologics Inc.Sold out | February 14, 2022 | 0 | 0.0% |
| Athira Pharma, Inc.Sold out | February 14, 2022 | 0 | 0.0% |
View VIKING GLOBAL INVESTORS LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 3 | 2024-03-20 |
| SC 13G/A | 2024-03-20 |
| 4 | 2024-03-07 |
| 4 | 2024-03-07 |
| 4 | 2024-03-01 |
| 4 | 2024-03-01 |
| SC 13G/A | 2024-03-01 |
| 4 | 2024-02-28 |
| 4 | 2024-02-28 |
| SC 13G/A | 2024-02-28 |
View VIKING GLOBAL INVESTORS LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.